Intensive blood pressure control and risks of cognitive outcomes in patients with new-onset orthostatic hypotension.

Background Orthostatic hypotension (OH) increases the risk of dementia. Although intensive blood pressure (BP) lowering may have cognitive benefits regardless of baseline OH status, its effects in participants who develop OH during intervention remain unknown. Methods Participants of the Systolic Bl...

Descripción completa

Detalles Bibliográficos
Publicado en:Age & Ageing Vol. 55; no. 1; pp. 1 - 10
Autores principales: Wang, Siyu, Wang, Jingya, Wang, Yueyue, Xu, Xiaoli, Gu, Haoqing, Xie, Wanting, Cai, Le, Zhang, Junheng, Wang, Tiange, Zhao, Zhiyun
Formato: Artículo
Publicado: Oxford University Press / USA Jan2026
Materias:
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ssf&AN=192513131&site=ehost-live
header:
  @attributes:
    shortDbName: ssf
    uiTerm: 192513131
    longDbName: Social Sciences Full Text (H.W. Wilson)
    uiTag: AN
  controlInfo:
    bkinfo:
    jinfo:
      jid:
        00020729
        AGA
      jtl: Age & Ageing
      issn: 00020729
      maglogo: N
    pubinfo:
      dt: Jan2026
      vid: 55
      iid: 1
      pid: 622
      pub: Oxford University Press / USA
    artinfo:
      ui:
        192513131
        10.1093/ageing/afag005
      ppf: 1
      ppct: 9
      formats:
      tig:
        atl: Intensive blood pressure control and risks of cognitive outcomes in patients with new-onset orthostatic hypotension.
      aug:
        au:
          Wang, Siyu
          Wang, Jingya
          Wang, Yueyue
          Xu, Xiaoli
          Gu, Haoqing
          Xie, Wanting
          Cai, Le
          Zhang, Junheng
          Wang, Tiange
          Zhao, Zhiyun
        affil:
          Department of Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, ChinaNational Clinical Research Center for Metabolic Diseases (Shanghai), Key Laboratory for Endocrine and Metabolic Diseases of the National Health Commission of the PR China, Shanghai Key Laboratory for Endocrine Tumor, State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
          Lifecycle Health Management Center, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
          College of Health Science and Technology, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China
          College of Public Health, Shanghai Jiao Tong University, Shanghai 200025, China
      su:
        Randomized controlled trials
        Dementia risk factors
        Cognition disorder risk factors
        Risk assessment
        Data analysis
        T-test (Statistics)
        Research funding
        Frail elderly
        Antihypertensive agents
        Treatment effectiveness
        Chi-squared test
        Descriptive statistics
        Kaplan-Meier estimator
        Log-rank test
        Statistics
        Orthostatic hypotension
        Blood pressure
        Data analysis software
        Proportional hazards models
        Evaluation
        Disease complications
      sug:
        subj:
          Randomized controlled trials
          Pharmaceutical and medicine manufacturing
          Dementia risk factors
          Cognition disorder risk factors
          Risk assessment
          Data analysis
          T-test (Statistics)
          Research funding
          Frail elderly
          Antihypertensive agents
          Treatment effectiveness
          Chi-squared test
          Descriptive statistics
          Kaplan-Meier estimator
          Log-rank test
          Statistics
          Orthostatic hypotension
          Blood pressure
          Data analysis software
          Proportional hazards models
          Evaluation
          Disease complications
      keyword:
        blood pressure
        blood pressure regulation
        copyrightHolder:British Geriatrics Society
        copyrightYear:2026
        dementia
        https://dx.doi.org/10.1093/ageing/afag005
        inLanguage:en
        intensive blood pressure control
        mild cognitive impairment
        minimal cognitive impairment
        older people
        orthostatic hypotension
        probable dementia
        publisher:Oxford University Press
        randomization
        sameAs:https://pubmed.ncbi.nlm.nih.gov/41609319/
        sprint trial
        systolic blood pressure
        blood pressure
        blood pressure regulation
        copyrightHolder:British Geriatrics Society
        copyrightYear:2026
        dementia
        https://dx.doi.org/10.1093/ageing/afag005
        inLanguage:en
        intensive blood pressure control
        mild cognitive impairment
        minimal cognitive impairment
        older people
        orthostatic hypotension
        probable dementia
        publisher:Oxford University Press
        randomization
        sameAs:https://pubmed.ncbi.nlm.nih.gov/41609319/
        sprint trial
        systolic blood pressure
      ab: Background Orthostatic hypotension (OH) increases the risk of dementia. Although intensive blood pressure (BP) lowering may have cognitive benefits regardless of baseline OH status, its effects in participants who develop OH during intervention remain unknown. Methods Participants of the Systolic Blood Pressure Intervention Trial (SPRINT) were randomised to either intensive treatment (systolic BP target <120 mmHg) or standard treatment (systolic BP target <140 mmHg). This post hoc analysis defined new-onset OH as a systolic BP reduction ≥20 mmHg and/or a diastolic BP reduction ≥10 mmHg from a seated to a standing position at any follow-up visit during intervention. The primary outcome was probable dementia. Other outcomes included mild cognitive impairment (MCI), and a composite of probable dementia or MCI. Results Amongst 7911 participants without OH at baseline (representing 84.5% of randomised participants in SPRINT; mean age, 67.7 years; 34.7% women), 1264 (16.0%) developed new-onset OH during intervention. Intensive treatment was associated with a lower risk of probable dementia (HR, 0.76; 95% CI, 0.58 to 0.98) amongst participants without new-onset OH, but with a higher risk (HR, 2.39; 95% CI, 1.33 to 4.32) amongst participants with new-onset OH. No significant association was observed between intensive treatment and MCI, or the composite outcome in participants with new-onset OH. Conclusions The occurrence of OH requires close monitoring, with caution for potential cognitive adverse effects during ongoing intensive BP-lowering treatment. Validation of current findings in studies with justified methodological designs is warranted. Registration URL: ClinicalTrials.gov ; Unique Identifier: NCT01206062.
      pubtype: Academic Journal
      doctype: Article
      src: R
    language: English
    refInfo:
    copyright:
      @attributes:
        flag: N
    holdings:
      @attributes:
        islocal: N